OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Showing 23 citing articles:
Longitudinal antibody dynamics after COVID-19 vaccine boosters based on prior infection status and booster doses
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 201-210
Open Access | Times Cited: 9
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 201-210
Open Access | Times Cited: 9
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination
Carla Martín Pérez, Ruth Aguilar, Alfons Jiménez, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Carla Martín Pérez, Ruth Aguilar, Alfons Jiménez, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity
Fernanda Ana‐Sosa‐Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
EBioMedicine (2025) Vol. 113, pp. 105619-105619
Open Access
Fernanda Ana‐Sosa‐Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
EBioMedicine (2025) Vol. 113, pp. 105619-105619
Open Access
Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in China
Xiaolong Yan, Xin Zhao, Yin Du, et al.
International Journal of Infectious Diseases (2024) Vol. 145, pp. 107075-107075
Open Access | Times Cited: 4
Xiaolong Yan, Xin Zhao, Yin Du, et al.
International Journal of Infectious Diseases (2024) Vol. 145, pp. 107075-107075
Open Access | Times Cited: 4
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
Peter Kirwan, Victoria Hall, Sarah Foulkes, et al.
The Lancet Regional Health - Europe (2023) Vol. 36, pp. 100809-100809
Open Access | Times Cited: 11
Peter Kirwan, Victoria Hall, Sarah Foulkes, et al.
The Lancet Regional Health - Europe (2023) Vol. 36, pp. 100809-100809
Open Access | Times Cited: 11
Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus
Jakub Swadźba, Andrzej Panek, Paweł Wąsowicz, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 471-471
Open Access | Times Cited: 1
Jakub Swadźba, Andrzej Panek, Paweł Wąsowicz, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 471-471
Open Access | Times Cited: 1
Opportunities to strengthen respiratory virus surveillance systems in Australia: lessons learned from the COVID-19 response
Freya M. Shearer, Laura Edwards, Martyn Kirk, et al.
Communicable Diseases Intelligence (2024) Vol. 48
Open Access | Times Cited: 1
Freya M. Shearer, Laura Edwards, Martyn Kirk, et al.
Communicable Diseases Intelligence (2024) Vol. 48
Open Access | Times Cited: 1
Anti‐Spike IgG antibodies as correlates of protection against SARS‐CoV‐2 infection in the pre‐Omicron and Omicron era
Lisa Seekircher, Manfred Astl, Lena Tschiderer, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access | Times Cited: 1
Lisa Seekircher, Manfred Astl, Lena Tschiderer, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access | Times Cited: 1
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients
Maria Antonella Zingaropoli, Mariasilvia Guardiani, Federica Dominelli, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 224-224
Open Access | Times Cited: 1
Maria Antonella Zingaropoli, Mariasilvia Guardiani, Federica Dominelli, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 224-224
Open Access | Times Cited: 1
Omicron BA.4/5 neutralization and cell‐mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow‐up cohort study
Haoting Zhan, Yuchen Xie, Yongmei Liu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access
Haoting Zhan, Yuchen Xie, Yongmei Liu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access
Hybrid Immunity and Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study
James K. Romine, Huashi Li, Melissa M. Coughlin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 96-107
Closed Access
James K. Romine, Huashi Li, Melissa M. Coughlin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 96-107
Closed Access
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection
David Niklas Springer, Simon Daller, Michael Knappik, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 822-822
Open Access
David Niklas Springer, Simon Daller, Michael Knappik, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 822-822
Open Access
Immune responses and reinfection of SARS‐CoV ‐2 Omicron variant in patients with lung cancer
Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 8, pp. 1409-1421
Closed Access
Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 8, pp. 1409-1421
Closed Access
Serum anti-nucleocapsid antibody level induced after primary infection is an immunological surrogate of protection against SARS-CoV-2 re-infection in hybrid immunity holders
Shô Miyamoto, Koki Numakura, Ryo Kinoshita, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Shô Miyamoto, Koki Numakura, Ryo Kinoshita, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
James Hollister, Cynthia Porter, Ryan Sprissler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
James Hollister, Cynthia Porter, Ryan Sprissler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach
Daniel J. Phillips, Maria D. Christodoulou, S Feng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Daniel J. Phillips, Maria D. Christodoulou, S Feng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Proteome-Wide Analysis of Antibody Responses in Asymptomatic Omicron BA.2-Infected Individuals at the Amino Acid Resolution
Hongye Wang, Huixia Gao, Mansheng Li, et al.
Journal of Proteome Research (2024)
Closed Access
Hongye Wang, Huixia Gao, Mansheng Li, et al.
Journal of Proteome Research (2024)
Closed Access
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
James Hollister, Cynthia Porter, Ryan Sprissler, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0306953-e0306953
Open Access
James Hollister, Cynthia Porter, Ryan Sprissler, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0306953-e0306953
Open Access
Anti-SARS-CoV-2 IgG Antibody Response in Individuals Infected Post Complete Vaccination: A 6-Month Longitudinal Study in Healthcare Professionals
Nicole Baratto, Lorenza Maistrello, E.P. Pazienza, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1077-1077
Open Access | Times Cited: 1
Nicole Baratto, Lorenza Maistrello, E.P. Pazienza, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1077-1077
Open Access | Times Cited: 1
Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England
Catherine Quinot, Rachel Lunt, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Catherine Quinot, Rachel Lunt, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Protection of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
Peter Kirwan, Victoria Hall, Sarah Foulkes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Peter Kirwan, Victoria Hall, Sarah Foulkes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
